流感疫苗接种对老年糖尿病患者住院结局的效果
本研究汇总北京市老年流感疫苗接种信息登记数据库和北京市城镇职工基本医疗保险数据库(2013—2018年)中27620例老年糖尿病患者的住院记录,采用广义线性回归和倾向性评分匹配估计流感疫苗接种对住院结局的影响。倾向性评分匹配显示,流感高峰季节接种疫苗可降低院内死亡风险(OR:0.47[0.22,0.97])和再入院风险(OR:0.70[0.60,0.81]),缩短住院时长(β:-1.32[-1.47,-1.17])并降低医疗费用(GMR:0.90[0.88,0.92])。调整未测量混杂因素后,疫苗接种与再入院风险降低17%(OR比值:0.83[0.69,1.02])及住院时长缩短(β差值:-0.23[-0.62,0.16])相关。
要点
- 流感高峰季节接种疫苗可降低老年糖尿病患者院内死亡风险(OR:0.47[0.22,0.97])和再入院风险(OR:0.70[0.60,0.81])。
- 接种疫苗与住院时长缩短(β:-1.32[-1.47,-1.17])和医疗费用降低(GMR:0.90[0.88,0.92])相关。
- 年龄更大、健康状况更差的男性患者接种后可能获益更多。
核心结论
- 流感疫苗接种可显著改善老年糖尿病患者的住院结局。
- 这为低收入和中等收入国家针对脆弱人群实施免费流感疫苗接种政策提供了证据支持。
研究设计与样本
- 本研究汇总北京市老年流感疫苗接种信息登记数据库(2013—2018年)和北京市城镇职工基本医疗保险数据库(2013—2018年)记录的27620例老年糖尿病患者的住院数据。
- 采用广义线性回归和倾向性评分匹配估计流感疫苗接种对住院结局的影响,并调整可测量的混杂因素。
- 以流感低发期(5—7月)为参照期,调整流感高峰季节(11—1月)的未测量混杂因素。
主要发现
- 倾向性评分匹配中,流感高峰季节接种疫苗可降低院内死亡风险(OR:0.47[0.22,0.97])和再入院风险(OR:0.70[0.60,0.81])。
- 倾向性评分匹配中,接种疫苗与住院时长缩短(β:-1.32[-1.47,-1.17])和医疗费用降低(GMR:0.90[0.88,0.92])相关。
- 调整未测量混杂因素后,接种疫苗与再入院风险降低17%(OR比值:0.83[0.69,1.02])及住院时长缩短(β差值:-0.23[-0.62,0.16])相关。
- 亚组分析显示,年龄更大、健康状况更差的男性患者接种后可能获益更多。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: In older populations admitted for diabetes, limited evidence suggests that influenza vaccination protects against hospitalization outcomes. METHODS: This study pooled 27,620 hospitalizations recorded for elderly diabetes patients from the Beijing Elderly Influenza Vaccination Information Registration Database (2013-2018) and the Beijing Urban Employee Basic Medical Insurance Database (2013-2018). Generalized linear regression and propensity score matching were conducted to estimate the effects of influenza vaccination on hospitalization outcomes (in-hospital all-cause mortality, readmission, length and costs of hospitalization), adjusting for measurable confounding factors. The low influenza period (May-July) was used as a reference period to adjust for unmeasured confounding factors during the peak influenza period (November-January). RESULTS: In propensity score matching, influenza vaccination in peak influenza period could reduce the risk of in-hospital death (OR: 0.47[0.22,0.97]) and readmission (OR: 0.70[0.60,0.81]), length of hospitalization (β: -1.32[-1.47, -1.17]) and medical costs (GMR: 0.90[0.88,0.92]). After adjusting for unmeasured confounding factors, influenza vaccination was associated with 17% (ratio of ORs: 0.83 [0.69, 1.02]) lower risk of readmission and shorter length of hospitalization (difference in β: -0.23 [-0.62, 0.16]). The subgroup analyses showed that male patients with older age and poorer health conditions could benefit more after influenza vaccination. CONCLUSION: Influenza vaccination could significantly improve hospitalization outcomes in elderly diabetic patients. This provides evidence supporting free influenza vaccination policies for vulnerable populations in low- and middle-income countries.
引用
- Liu G, Pang Y, Lv M, et al. Effectiveness of influenza vaccination on hospitalization outcomes among older patients with diabetes. Vaccine. 2024. PMID: 39019658. doi:10.1016/j.vaccine.2024.07.043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。